This site is intended for healthcare professionals

What’s next? PARP inhibitor combination treatments in different clinical settings for ovarian cancer

In session 3, Professor Nicoletta Colombo discusses the future of PARP inhibitor therapy, covering PARP inhibitor combination treatments and the types of patients this would benefit.